Skip to content

The Value of Multimode Imaging Technology in Transcranial Magnetic Stimulation Treatment of Psychotype Diseases

The Value of Multimode Imaging Technology in Transcranial Magnetic Stimulation Treatment of Psychotype Diseases

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048390
Enrollment
Unknown
Registered
2021-07-06
Start date
2021-06-30
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Diseases

Interventions

Single arm clinical trial:Transcranial magnetic stimulation

Sponsors

He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Chinese male and female adults aged >= 18 years of age and provide written informed consent prior to any research-related procedures; 2.A psychologist is identified as suffering from a mental illness based on a clinical history and examination; 3.Patients without MRI scans and transcranial magnetic treatment of contraindications.

Exclusion criteria

Exclusion criteria: 1.There are other mental disorders, such as schizophrenia; 2.There are serious neurological disorders, such as brain tumors or intracranial infections; 3.Subjects whose weight exceeds the upper load limit of the treatment bed or who are not suitable for MRI scans; 4.Have a history of seizures, genetic disorders or brain abnormalities.

Design outcomes

Primary

MeasureTime frame
Functional rating scale;Functional magnetic resonance imaging;

Countries

China

Contacts

Public ContactWang Meiyun

He'nan Provincial People's Hospital

mywang@ha.edu.cn+86 15617167967

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026